Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 222-233
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.222
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.222
Table 1 Patient, tumor and treatment characteristics
| All cases | N (%) |
| Sex, n (%) | |
| Male | 26 (72.2) |
| Female | 10 (27.8) |
| Age, yr (median) | 52.0 |
| ECOG | |
| 0 | 2 (5.6) |
| 1 | 30 (83.3) |
| 2 | 4 (11.1) |
| Tumor location, n (%) | |
| Stomach | 3 (8.3) |
| Duodenum | 3 (8.3) |
| Colorectal cancer | 30 (83.3) |
| Clinical TNM stage, n (%) | |
| II-III | 27(75.0) |
| IV | 9 (25.0) |
| Lynch syndrome | |
| Yes | 16 (44.4) |
| No | 20 (55.6) |
| No clear | 0 (0.0) |
| MMR and MSI status | |
| Consistent | 30 (83.3) |
| Inconsistent | 6 (16.7) |
- Citation: Li YJ, Liu XZ, Yao YF, Chen N, Li ZW, Zhang XY, Lin XF, Wu AW. Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies. World J Gastrointest Surg 2023; 15(2): 222-233
- URL: https://www.wjgnet.com/1948-9366/full/v15/i2/222.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.222